switzerlanden
When factors disagree

When factors disagree

30-09-2014 | Research

Generic strategies designed to harvest a certain factor premium regularly conflict with other factor premiums. We find that the premiums associated with these strategies tend to shrink, sometimes even to zero, in these periods of factor disagreement. But enhanced factor strategies avoid stocks that are unattractive on other established factors and continue to deliver when generic factor strategies struggle.

  • Bart van der Grient
    Bart
    van der Grient
    Reseacher
  • Pim  van Vliet, PhD
    Pim
    van Vliet, PhD
    Lead Portfolio Manager Conservative Equities
  • David Blitz
    David
    Blitz
    Chief Researcher

Speed read:

  • Generic factor indices often conflict with other established factors
  • Robeco’s enhanced strategy avoids stocks that are unattractive on other factors
  • Enhanced strategies offer stronger, more consistent performance

Two approaches: generic and enhanced

A factor investing strategy can be implemented in various ways. The main distinction that can be made is between generic approaches and enhanced approaches. The generic approach is to passively follow an index which is designed to actively benefit from a factor premium using a fully transparent, rules-based approach. A potential pitfall of such indices is that although they may provide exposure to a certain factor, they may, at the same time, be conflicting with other established factors. This is actually not unusual. For instance, value-tilted indices can become quite risky at certain times, thereby betting implicitly against the low-volatility premium, and momentum strategies have the structural tendency to select stocks which have become quite expensive.

Going against the value premium can also be a concern for generic low-volatility strategies, which, for instance, exhibit a higher P/E than the market in recent years. Robeco’s enhanced factor strategies are different, because one of their distinguishing features is that they are explicitly designed to avoid stocks that are unattractive on other established factors.

Stay informed on Quant investing with monthly mail updates
Stay informed on Quant investing with monthly mail updates
Subscribe

The performance of generic and enhanced factor strategies

We have comprehensively examined the performance of both types of factor strategies. We found out that the more (less) a factor strategy is aligned with other factors, the stronger (weaker) its subsequent performance. In addition, the Robeco enhanced strategies turn out to offer a more consistent performance than generic approaches, because a key element of our investment philosophy is taking exposures to other factors explicitly into account.

Enhanced strategies deliver when generic strategies struggle

This improvement is particularly welcome when generic factor strategies struggle, because of their relatively unfavorable exposures to other factors. We observe that the enhanced factor strategies are still able to deliver in these scenarios. For instance, the enhanced momentum strategy generates over 3% outperformance when generic momentum is relatively expensive or risky and therefore hardly able to offer any added value. In a similar fashion, the enhanced low-volatility strategy manages to deliver 2-3% return over the cap-weighted index when generic low-volatility has a relatively high valuation or weak momentum and actually lags.

These results imply that it is crucial to properly align factor exposures when implementing a factor investing approach.

Leave your details and download the report

Disclaimer

This report is not available for users from countries where the offering of foreign financial services is not permitted, such as US Persons.

Your details are not shared with third parties. This information is exclusively intended for professional investors. All requests are checked.

Logo

Disclaimer Robeco Switzerland Ltd.

The information contained on these pages is for marketing purposes and solely intended for Qualified Investors in accordance with the Swiss Collective Investment Schemes Act of 23 June 2006 (“CISA”) domiciled in Switzerland, Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in the European Union und European Economic Area with a license to distribute / promote financial instruments in such capacity or herewith requesting respective information on products and services in their capacity as Professional Clients. 

The Funds are domiciled in Luxembourg and The Netherlands. ACOLIN Fund Services AG, postal address: Affolternstrasse 56, 8050 Zürich, acts as the Swiss representative of the Fund(s). UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich, postal address: Europastrasse 2, P.O. Box, CH-8152 Opfikon, acts as the Swiss paying agent. The prospectus, the Key Investor Information Documents (KIIDs), the articles of association, the annual and semi-annual reports of the Fund(s) may be obtained, on simple request and free of charge, at the office of the Swiss representative ACOLIN Fund Services AG. The prospectuses are also available via the website www.robeco.ch. Some funds about which information is shown on these pages may fall outside the scope of the Swiss Collective Investment Schemes Act of 26 June 2006 (“CISA”) and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA). 

Some funds about which information is shown on this website may not be available in your domicile country. Please check the registration status in your respective domicile country. To view the RobecoSwitzerland Ltd. products that are registered/available in your country, please go to the respective Fund Selector, which can be found on this website and select your country of domicile. 

Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco Switzerland Ltd. product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports. 

By clicking “I agree” you confirm that you/the company you represent falls under one of the above-mentioned categories of addressees and that you have read, understood and accept the terms of use for this website.

I Disagree